Growth & Innovation Strategy
Newry works with specialty chemicals, advanced materials, and industrial companies to find exactly where growth is stalling – and map a clear path forward.
40 years of technical depth · 1,100+ projects completed
Growth Strategy
Adjacent market identification, core market headroom analysis, organic and inorganic growth planning, and right-to-win assessment. Grounded in primary research in your specific technical markets.
Growth Strategy →Private Equity
Commercial due diligence, Quality of Revenue assessment, portfolio company growth strategy, and exit preparation. Newry's technical market depth is the difference in sector-specific diligence where generalist firms miss what matters.
Private Equity →Innovation & R&D
Technology scouting, adjacent application identification, IP strategy, Stage-Gate process design, and R&D portfolio prioritization. We identify which technical capabilities translate to defensible market positions.
Innovation & R&D →M&A Advisory
Target identification, commercial due diligence, market sizing validation, synergy assessment, and post-merger growth strategy. Focused on technical markets where the thesis depends on understanding what the customer actually values.
M&A Advisory →A structured four-phase process – from gap diagnosis to sustainable results – built around your specific markets, not a generic playbook.
01 – Diagnose
Map where your growth engine is breaking – strategy gaps, execution gaps, and competitive disruption risk – before defining where to invest.
02 – Define
Where to play and how to win. Adjacent market identification, right-to-win assessment, business model design – grounded in outside-in evidence.
03 – Drive
Embed execution against four commercial levers: Pricing & Margin, Salesforce Effectiveness, Marketing & Demand Gen, and organic or M&A growth.
04 – Sustain
Team capability building, performance monitoring, and tool deployment where appropriate – so results compound beyond the engagement.
Outside-in intelligence built in: Newry's process compresses weeks of market scanning and competitive analysis into days – surfacing evidence your internal team doesn't have the bandwidth to build.
A PE-owned specialty chemicals distributor set out to grow EBITDA 3x within five years supplying the coatings, adhesives, sealants & elastomers (CASE) industry. Newry spent a year profiling adjacent markets and testing headroom in existing resin lines, then embedded directly with the CEO to execute – surfacing roughly $24M in EBITDA impact and helping stand up a new product platform now expected to contribute 30% of total EBITDA within five years.
A leading fixture and water-management company needed to understand IoT-based growth opportunities but had little visibility into market dynamics, consumer demand, or the capabilities connected products would require. Over three years, Newry ran extensive consumer and industry research, facilitated key technology partnerships, and helped shape a first-of-its-kind connected product that grew into a full platform.
Newry was fantastic! They are incredibly knowledgeable, sought the right answers to all the tough questions, and did a great job of decomposing the opportunities for us.Executive VP, Global Sales and Marketing – Medical Device Components Manufacturer
Newry is able to think differently. They're smart but pragmatic – they have this kind of cleverness and curiosity.CEO – PE-Backed Additives Company
Big firms aren't as good as Newry at highly technical opportunities. I've never seen anybody provide analysis like this.VP Advanced Technology – Fortune 500 Company
Newry has operated at the intersection of technical markets and growth strategy since 1987. We've guided billions in investment decisions across specialty chemicals, advanced materials, automotive, building products, and industrial manufacturing – in markets where the wrong call is expensive and generalist advice doesn't cut it.
Meet our team →Practical frameworks and field-tested perspectives on growth, adjacency strategy, and commercial excellence in technical markets.
Strategic Perspectives
Most value creation plans don't fail because they're wrong. They fail because the organization can't execute them while running the business.
Read →Strategic Perspectives
Private equity firms have a unique opportunity to create more value through purposeful organic and inorganic growth – and turn potential into measurable performance.
Read →Strategic Perspectives
Being a specialty chemicals or polymers purveyor is much like being a fine concierge – three paths to remain specialty, with healthy margins, in an increasingly commoditized world.
Read →